Incyte Corp (INCY): Depreciation & Amortization
$93.29M
Year ended 2025-12-31
$94.73M
Trailing 12 months to 2026-03-31
+11.2%
3-year compound annual growth
+12.5%
5-year compound annual growth
+7.6%
10-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $93.29M | +4.5% | 2026-02-10, From 2025-01-01 |
| 2024-12-31 | $89.25M | +8.0% | 2026-02-10, From 2024-01-01 |
| 2023-12-31 | $82.66M | +21.8% | 2026-02-10, From 2023-01-01 |
| 2022-12-31 | $67.86M | +17.3% | 2025-02-10, From 2022-01-01 |
| 2021-12-31 | $57.84M | +11.7% | 2024-02-13, From 2021-01-01 |
| 2020-12-31 | $51.81M | -5.0% | 2023-02-07, From 2020-01-01 |
| 2019-12-31 | $54.53M | -0.8% | 2022-02-08, From 2019-01-01 |
| 2018-12-31 | $54.97M | +5.3% | 2021-02-09, From 2018-01-01 |
| 2017-12-31 | $52.18M | -10.7% | 2020-02-13, From 2017-01-01 |
| 2016-12-31 | $58.42M | +30.2% | 2019-02-14, From 2016-01-01 |
| 2015-12-31 | $44.88M | +8.4% | 2018-02-15, From 2015-01-01 |
| 2014-12-31 | $41.41M | +41.8% | 2017-02-14, From 2014-01-01 |
| 2013-12-31 | $29.21M | -2.6% | 2016-02-12, From 2013-01-01 |
| 2012-12-31 | $29.98M | +11.1% | 2015-02-17, From 2012-01-01 |
| 2011-12-31 | $26.99M | +10.2% | 2014-02-21, From 2011-01-01 |
| 2010-12-31 | $24.48M | +46.7% | 2013-02-21, From 2010-01-01 |
| 2009-12-31 | $16.69M | n/a | 2012-02-22, From 2009-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Incyte Corp (INCY) | 2025-12-31 | $93.29M | +4.5% |
| Charles River Laboratories International, Inc. (CRL) | 2025-12-27 | $403.31M | +11.5% |
| Icon PLC (ICLR) | 2025-12-31 | $383.00M | -21.6% |
| Iqvia Holdings Inc. (IQV) | 2025-12-31 | $1.14B | +2.7% |
| NRC Health (NRC) | 2025-12-31 | $7.62M | +26.6% |
| MaxCyte, Inc. (MXCT) | 2025-12-31 | $4.34M | +0.6% |
| OmniAb, Inc. (OABI) | 2025-12-31 | $21.75M | -7.8% |
| Foxo Technologies Inc. (FOXO) | 2025-12-31 | $597.4K | -51.6% |
| bioAffinity Technologies, Inc. (BIAF) | 2025-12-31 | $504.8K | -16.6% |
Compare INCY, CRL, ICLR, IQV side by side · Screen every company in Services-Commercial Physical & Biological Research ↗